Table 2 Expression of Tribbles increased... | American Society of Hematology

Table 2

Expression of Tribbles increased in subsets of AML compared with healthy samples

Studies	Trib1 (202241_at)		Trib2 (202478_at)		Trib3 (218145_at)
Studies	Karyotype	FAB	Karyotype	FAB	Karyotype	FAB
Valk et al⁹	inv(16) or t(16;16)*	M4*	NS	NS	t(8;21)*	M2*
Valk et al⁹	inv(16) or t(16;16)*	M5*	NS		t(15;17)†	M3†
Haferlach et al¹²	NS	—	NS	—	complex†	—
Haferlach et al¹²	NS	—	NS	—	t(15;17)*	—

Studies	Trib1 (202241_at)		Trib2 (202478_at)		Trib3 (218145_at)
Studies	Karyotype	FAB	Karyotype	FAB	Karyotype	FAB
Valk et al⁹	inv(16) or t(16;16)*	M4*	NS	NS	t(8;21)*	M2*
Valk et al⁹	inv(16) or t(16;16)*	M5*	NS		t(15;17)†	M3†
Haferlach et al¹²	NS	—	NS	—	complex†	—
Haferlach et al¹²	NS	—	NS	—	t(15;17)*	—

Elevated expression of Tribbles in karyotypes and FAB subytypes identified in Table 1 were compared with that of healthy samples. Healthy samples were not available in Gutierrez et al,¹⁰ Verhaak et al¹¹ and Eppert et al.¹³

Abbreviations are explained in Table 1.

Statistically significant increased expression with adjusted P < .05 in Welch’s t test.

†

Statistically highly significant increased expression with adjusted P < .001 in Welch’s t test.

View Large

This Feature Is Available To Subscribers Only